Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/jspui/handle/10553/157542
Título: Donation after circulatory death in a European ultraperipheral and multi-insular region
Autores/as: Groba Marco, María Del Val 
Fernández De Sanmamed Girón, Miguel 
Galván Ruíz, Mario 
Pena Morant, V
Romero Lujan, J. L.
Gonzalez Martin, J.
Portela Torrón, Francisco Antonio 
Deniz Rosario, J.
Acosta Calero,Carmen 
Rojas Escriva, B.
Grillo Perez, J.
Belleyo Belkasem, K.
Marrero Negrin, N.
Caballero Dorta, Eduardo José 
Garcia Quintana, A.
Clasificación UNESCO: 32 Ciencias médicas
320501 Cardiología
Palabras clave: Heart transplantation
Medical records
Ventricular dysfunction
Left
Brain death, et al.
Fecha de publicación: 2025
Publicación seriada: European Heart Journal 
Conferencia: ESC Congress 2025 Madrid together with World Congress of Cardiology 
Resumen: Background The creation of a new heart transplant (HT) program in a ultraperipheral region may be limited by a small population and a shortage of cardiac donors. In recent years, controlled donation after circulatory death (DCD) has significantly increased transplant activity. This study aims to evaluate the characteristics and outcomes of DCD using thoraco-abdominal normothermic regional perfusion (TANRP) and static cold storage compared to traditional donation after brain death (DBD) in the XXX HT program. Method We performed a single-center, retrospective observational study of all HT performed between December 2019 and December 2024 in the XXX hospital. Data were obtained from medical records and the XXX HT Registry. Results The first DCD transplant was performed in 2021, and in subsequent years 4 ,7 and 8 HT were procured using this technique (Figure 1A). During the study period, 98 HT were performed and 20% were from DCD. These donors had a similar age compared to DBD donors (49.8 vs. 46.4 years, p = 0.321), were mostly male (80%), and one patient had left ventricular dysfunction during the intraoperative DCD process. Mean waitlist time was shorter in the DCD group (27 vs 66 days, p = 0.03). There were no differences in primary graft dysfunction (10% in the DCD group and 9% in DBD, p = 1) or renal replacement therapy (50% vs 26%, p = 0.055). Median total hospital stay was longer in the DCD group (46 vs 36 days, p = 0.021). In the DCD group, at 1, 6, 12 and 24 months the survival rate was 96%, 95%, 93% and 87%, respectively, with no significant differences compared to the DBD group (Figure 1B). Conclusions In the first HT program in a European ultraperipheral and multi-insular region, DCD is performed safely and effectively without compromising outcomes, and with a significant increase in donor pool. This HT program employed older donors, than those reported in previous studies, with excellent short-term outcomes. Future studies are warranted.
URI: https://accedacris.ulpgc.es/jspui/handle/10553/157542
ISSN: 0195-668X
DOI: 10.1093/eurheartj/ehaf784.1367
Fuente: European Heart Journal[ISSN 0195-668X],v. 46 sup. 1, #ehaf784.1367 (Noviembre 2025)
Colección:Actas de congresos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.